Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GSK2251052 in Complicated Urinary Tract Infection

This study has been terminated.
(Microbiological findings of resistance on therapy in patients with complicated urinary tract infection)
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01381549
First received: June 9, 2011
Last updated: July 24, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: November 15, 2012
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):